½ÃÀ庸°í¼­
»óǰÄÚµå
1621953

¼¼°èÀÇ ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ¹üÀ§ ¹× ¿¹Ãø

Global Airway Stent/Lung Stent Market size By Product (Tracheal Stents, Laryngeal Stents), By Application (Hospitals, Ambulatory Surgery Centers), By Geographic Scope And Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ½ÃÀå ±Ô¸ð´Â 2024³â 8,783¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2031³â¿¡´Â 1¾ï 4,716¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 6.68% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀåÀº Æó¾Ï°ú °°Àº ³­Ä¡¼º Áúȯ Ä¡·á¿¡ ´ëÇÑ ÃÖ¼Òħ½À¼ö¼ú(MIS)¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ºñÇ÷°ü ½ºÅÙÆ® °³¹ßÀ» À§ÇÑ °ø°ø ¹× ¹Î°£ ±â°üÀÇ R&D ÅõÀÚ Áõ°¡, ½Ç½Ã°£ È£Èí±â µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ½ºÅÙÆ® °³¹ß µî ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀåÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ºÎ¹®, µ¿Çâ, ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, °æÀï »óȲ, ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¿äÀÎ µîÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®ÇÕ´Ï´Ù.

±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå Á¤ÀÇ

±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ®´Â ¼ÓÀÌ ºó °ü ¸ð¾çÀÇ ±âµµ ±¸Á¶¸¦ ÁöÁöÇÏ°í °³Å뼺À» À¯ÁöÇÏ´Â ´Ù¾çÇÑ Àç·áÀÇ ±â°üÁö ³» Àΰø ±â°üÁöÀÔ´Ï´Ù. ±âµµ ½ºÅÙÆ®´Â Á¾¾çÀÌ ±âµµ·Î ÀüÀ̵Ǵ °ÍÀ» ¹æÁöÇϰí, ±âµµ ´©°øÀÇ Ä¡À¯ ¹× Á¶ÀýÀ» µ½°Å³ª, ±âµµ º®ÀÇ Àå¾Ö ¹× ¿ÜºÎÀÇ ÁýÁß¿¡ ´ëÀÀÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ºÅÙÆ®´Â ±Ý¼Ó, ½Ç¸®ÄÜ µî ´Ù¾çÇÑ Àç·á·Î ¸¸µé¾îÁý´Ï´Ù. Å©±â¿Í ¸ð¾çµµ ´Ù¾çÇÕ´Ï´Ù. ½ºÅÙÆ®´Â ÀϽÃÀûÀÎ °ÍºÎÅÍ ¿µ±¸ÀûÀÎ °Í±îÁö ´Ù¾çÇÕ´Ï´Ù. ±âµµ ½ºÅÙÆ® »ðÀÔ¼úÀº ¾Ç¼º ¹× ¾ç¼º °úÁ¤ÀÌ È¥ÇÕµÈ °æ¿ì¿¡ ½ÃÇàµË´Ï´Ù. ÀûÀÀÁõ¿¡ °ü°è¾øÀÌ ½ºÅÙÆ® »ðÀÔ Àü¿¡ ÈäºÎ ¿Ü°ú ÀÇ»ç ¶Ç´Â ÁßÀç Àû Æó Àü¹®ÀǴ ȯÀÚ°¡ ¿Ü°ú ÀûÀ¸·Î °¡¿ªÀû Àα⵵ ÁúȯÀÌ ¾ø´ÂÁö È®ÀÎÇØ¾ßÇÕ´Ï´Ù. ƯÈ÷ ½ºÅÙÆ® »ðÀÔÀ¸·Î º´º¯ÀÌ ÀϹÝÀûÀ¸·Î ±â°ü ÀýÁ¦¼ú¿¡ »ç¿ëµÇ´Â ÇѰèÀÎ 4cm¸¦ ÃʰúÇÏ´Â ±æÀÌ·Î È®ÀåµÇ´Â °æ¿ì ´õ¿í ±×·¸½À´Ï´Ù.

±âµµ ½ºÅÙÆ® »ç¿ëÀº Á¾Á¾ ÀϺΠÈäºÎ¿Ü°ú Àǻ糪 ÁßÀçÀû ÈäºÎ¿Ü°ú ÀÇ»çµé·ÎºÎÅÍ Á÷°üÀûÀÎ ¹Ý¹ßÀ» ºÒ·¯ÀÏÀ¸Å°´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Ý»çÀûÀÎ ¹Ý¹ßÀº °ú°Å Ä¡¸íÀûÀÎ »ç·ÊÀÇ °á°úÀ̰ųª Áöµµ Àǻ翡 ÀÇÇØ Á¤½Å¿¡ °­ÇÏ°Ô °¢ÀÎµÈ °á°úÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æ¿ì, Ư¼öÇÑ »ç·Ê, Ư¼öÇÑ È¯ÀÚ¿¡°Ô °¡´ÉÇÑ ¿É¼Ç, ±×¸®°í Çö´ë ±âµµ ½ºÅÙÆ®ÀÇ »ýü Àç·á¿Í °øÇп¡ ´ëÇÑ È®½ÇÇÑ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á¤È®ÇÑ ÇØ¼®ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ÀÇÇÐÀûÀ¸·Î ¾ç¼º ¶Ç´Â Ä¡¸íÀûÀÎ »óŸ¦ º¸Á¸Çϱâ À§ÇØ ¿Ü°úÀû °³ÀÔÀ» °æÇèÇÒ ¼ö Àִ ȯÀÚ´Â ¿µÇâÀ» ¹Þ´Â Àΰø±âµµ¸¦ ¼³Ä¡Çؼ­´Â ¾È µË´Ï´Ù. ¶ÇÇÑ ±â´ÉÀû ´É·Â¿¡ ¸Å¿ì °¡±î¿î Àå¾Ö°¡ ÀÖ°í ±â´ë ¼ö¸íÀÌ ¸Å¿ì ªÀº °æ¿ì ½ºÅÙÆ® »ðÀÔÀ» ¼öÇàÇØ¼­´Â ¾ÈµË´Ï´Ù.

±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå °³¿ä

¼¼°è ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ½ÃÀåÀº Æó¾Ï, ³ì³»Àå, ¸¸¼ºÆó¼â¼ºÆóÁúȯ, ÁßÃ߱⵵Æó¼â, õ½Ä µî ³­Ä¡¼º ÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ ÃÖ¼Òħ½À¼ö¼ú(MIS)¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Asian Pacific Journal of Cancer Prevention¿¡ µû¸£¸é, Æó¾Ï ȯÀÚÀÇ ¾à 30%°¡ ÁßÃß¼º ±âµµÆó¼â(CAO)¸¦ ÀÏÀ¸ÄÑ ½É°¢ÇÑ È£Èí±â ÇÕº´ÁõÀ» À¯¹ßÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±× °á°ú, ±âµµ ½ºÅÙÆ®ÀÇ »ç¿ë°ú »ç¿ëÀÌ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÕÀ¸·Îµµ Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñÇ÷°ü ½ºÅÙÆ® °³¹ßÀ» À§ÇÑ °ø°ø ¹× ¹Î°£ ±â°üÀÇ ¿¬±¸°³¹ß ÅõÀÚ È®´ë´Â ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 1¿ù ¹Ì±¹ FDA´Â ȯÀÚÀÇ ±âµµ¿¡ ¸Â°Ô Á¦ÀÛµÈ 3D ÇÁ¸°ÆÃ ±âµµ ½ºÅÙÆ®¸¦ ½ÂÀÎÇß½À´Ï´Ù.

¶ÇÇÑ, IoT ¹× µ¥ÀÌÅÍ °úÇаú °°Àº ¿ì¼öÇÑ ±â¼úÀ» »ç¿ëÇÏ¿© È£Èí±âÀÇ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ½ºÅÙÆ® °³¹ß°ú °°Àº ±â¼ú ¹ßÀüµµ ÃßÁ¤ ±â°£ µ¿¾È ¼¼°è ±âµµ ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º Æó ½ºÅÙÆ® ¹× ¾à¹° ¿ëÃ⼺ Æó ½ºÅÙÆ®ÀÇ °³¼±Àº ±âµµ ½ºÅÙÆ®ÀÇ Ã¤ÅÃÀ» È®´ëÇÏ°í ½ÃÀå ¼ºÀåÀ» °­È­ÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ½ºÅÙÆ® ÀåÂø¿¡ µû¸¥ ÇÕº´Áõ°ú »ç¿ë °¡´ÉÇÑ ¿©·¯ °¡Áö ´ëü Ä¡·á¹ýÀº ÀÏÁ¤ ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ã¹è Èí¿¬ÀÇ º¸±ÞÀÌ °¨¼ÒÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¶ÇÇÑ ½ÃÀåÀ» ¾ïÁ¦ÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå : ¼Ò°³

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • °¡Á¤

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå VERIFIED MARKET RESEARCH Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • ¹ë¸®µ¥À̼Ç
  • 1Â÷ ÀÎÅͺä
  • µ¥ÀÌÅÍ ¼Ò½º ¸®½ºÆ®

Á¦4Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ±â°ü ½ºÅÙÆ®
  • ÈĵΠ½ºÅÙÆ®

Á¦6Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå : ¿ëµµº°

  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦7Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • À¯·´
  • µ¶ÀÏ
  • ¿µ±¹
  • ÇÁ¶û½º
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • ÀϺ»
  • Àεµ
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°è ±âŸ Áö¿ª
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ±âµµ ½ºÅÙÆ®/Æó ½ºÅÙÆ® ¼¼°è ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • ±â¾÷ ½ÃÀå ¼øÀ§
  • ÁÖ¿ä °³¹ß Àü·«

Á¦9Àå ±â¾÷ °³¿ä

  • Boston Scientific
  • C.R. Bard
  • Taewoong Medical
  • Micro-Tech(Nanjing)
  • Teleflex
  • Merit Medical Systems
  • Cook Group
  • Novatech Sa
  • Endo-Flex
  • M.I. Tech
  • Efer Endoscopy
  • Fuji Systems
  • Hood Laboratories

Á¦10Àå ºÎ·Ï

  • °ü·Ã º¸°í¼­
ksm 25.01.13

Airway Stent/Lung Stent Market Size And Forecast

Airway Stent/Lung Stent Market size was valued at USD 87.83 Million in 2024 and is projected to reach USD 147.16 Million by 2031 , growing at a CAGR of 6.68% from 2024 to 2031. The Global Airway Stent/Lung Stent Market has witnessed strong growth owing to the increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions such as lung cancer, growing R&D investments by the public and private organizations for the development of non-vascular stents, and technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract. The Global Airway Stent/Lung Stent Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Airway Stent/Lung Stent Market Definition

An airway/lung stent is an endobronchial prosthesis of different materials that supports and preserves the patency of the hollow tubular airway structure. An airway stent may prevent the extension of a tumor into the airway, may help in the healing or control of airway fistulas, or may help the airway wall against failure or external concentration. Stents can be made of various materials, such as metal or silicone. They also come in various sizes and shapes. They can be momentary or permanent. Airway stenting is shown in a mixture of malignant and benign processes. Independent of the indication, before any stent placement, the thoracic surgeon or interventional pulmonologist must be sure that the sufferer does not have any surgically reversible airway disease. Stenting may involve or preclude surgery in some cases, especially when it extends the lesion to >4 cm in length, a generally used limit for tracheal resection.

The use of airway stents often elicits a visceral reaction from some thoracic surgeons and interventional pulmonologists. These reflexive rejoinders are the result of catastrophic cases in the past or are strongly ingrained in their psyche by their instructors. When this occurs, it is necessary to accurately interpret the particular case, the possible options for that special patient, and the solid data behind the biomaterials and engineering of contemporary airway stents. In general, patients medically able to experience surgical interventions to preserve benign or deadly conditions should not have an affected airway prosthesis placed. Also, very close impairment in functional capacity and very short survival expectancy should preclude stenting.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Airway Stent/Lung Stent Market Overview

The Global Airway Stent/Lung Stent Market is principally driven by increasing demand for MIS (Minimally Invasive Surgeries) for the treatment of persistent conditions including lung cancer, glaucoma, chronic obstructive pulmonary disease, central airway obstruction, asthma, etc. Patients suffering from lung cancer are inclined to suffer from breathing conditions. According to the Asian Pacific Journal of Cancer Prevention, around 30% of the patients suffering from lung cancer occur central airway obstruction (CAO) which results in severe breathing complications. As a result, the appropriation and utilization of airway stents have increased significantly and are anticipated to follow a similar trend in the following years. Growing R&D investments by the public and private organizations for the development of non-vascular stents is besides fueling the market growth. For example, in January 2020, the U.S. FDA approved 3D printed airway stent, which is produced to fit the patient's airway.

Additionally, technological advancements such as the development of innovative stents that can offer real-time data of the respiratory tract using excellent technologies like IoT and Data Science are also adding to the growth of the global airway stenting market during the estimated timeframe. The improvement of biodegradable and drug-eluting lung stents will also expand the adoption of airway stents, thus augmenting the growth of the market. However, complications connected with stent implementation and several alternative treatments available might restrain the growth of the market during the given time frame. Moreover, the pervasiveness of tobacco smoking has also been decreasing, which also acts as a restraint to the market.

Global Airway Stent/Lung Stent Market Segmentation Analysis

The Global Airway Stent/Lung Stent Market Segmented On The Basis Of Product, Application, And Geography.

Airway Stent/Lung Stent Market, By Product

  • Tracheal Stents
  • Laryngeal Stents
  • Bronchial Stents

Based on Product, the market is bifurcated into Tracheal Stents, Laryngeal Stents, and Bronchial stents. The bronchial stent segment is anticipated to grow at the highest CAGR during the forecast period owing to the high adoption of bronchial stents to treat respiratory disorders. Bronchial stents are additionally largely used in the treatment of hemoptysis following lung cancer and in the treatment of progressive dyspnea therefore, there is an enhanced demand for bronchial stents. Furthermore, bronchial stents are favored due to requirements such as palliative relief of symptoms, minimal invasiveness, and decreased chances of risks in surgeries.

Airway Stent/Lung Stent Market, By Application

  • Hospitals
  • Ambulatory Surgery Centers

Based on Application, the market is bifurcated into Hospitals and Ambulatory Surgery Centers. The Ambulatory Surgery Centers segment is estimated to witness the highest CAGR for the forecast period. Ambulatory surgical centers are more cost-effective than conventional hospitals and provide a shorter duration of stay post-surgery. Moreover, an increment in several ambulatory surgical centers and a rise in choice for minimally invasive surgeries are further factors enlarging the demand for lung stents.

Airway Stent/Lung Stent Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world.

Based on regional analysis, the Global Airway Stent/Lung Stent Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American airway stent market is estimated for the largest revenue share as of 2019 and it is anticipated to maintain its dominance during the forecast period. The presence of significant manufacturers, well-established healthcare infrastructure, and high awareness amongst the doctors ended in the rising adoption of these stents in this region. Moreover, the rising prevalence of diseases, growing geriatric population, and rising healthcare expenditure are also contributing to the growth of the market in this region.

Key Players

  • The "Global Airway Stent/Lung Stent Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Boston Scientific, C.R. Bard, Taewoong Medical, Micro-Tech (Nanjing), Teleflex, Merit Medical Systems, Cook Group, Novatech Sa, Endo-Flex, M.I. Tech, Ever Endoscopy, Fuji Systems, Hood Laboratories

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Airway Stent/Lung Stent Market

  • Overview of the Market
  • Scope of Report
  • Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

  • Data Mining
  • Validation
  • Primary Interviews
  • List of Data Sources

4. Global Airway Stent/Lung Stent Market Outlook

  • Overview
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Porters Five Force Model
  • Value Chain Analysis

5. Global Airway Stent/Lung Stent Market, By Product

  • Tracheal Stents
  • Laryngeal Stents

6. Global Airway Stent/Lung Stent Market, By Application

  • Hospitals
  • Ambulatory Surgery Centres

7. Global Airway Stent/Lung Stent Market, By Geography

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • Rest of the World
  • Latin America
  • Middle East & Africa

8. Global Airway Stent/Lung Stent Market Competitive Landscape

  • Overview
  • Company Market Ranking
  • Key Development Strategies

9. Company Profiles

  • Boston Scientific
  • C.R. Bard
  • Taewoong Medical
  • Micro-Tech (Nanjing)
  • Teleflex
  • Merit Medical Systems
  • Cook Group
  • Novatech Sa
  • Endo-Flex
  • M.I. Tech
  • Efer Endoscopy
  • Fuji Systems
  • Hood Laboratories

10. Appendix

  • Related Reports
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦